Post-IPO Equity - SAB Biotherapeutics
Investment Firm
Overview
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
Announced Date
Dec 07, 2022
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
SAB Biotherapeutics raised $7900000 on 2022-12-07 in Post-IPO Equity
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jan 18, 2023 |  Grant - SAB Biotherapeutics | 1 | - | 8.0M |
| Dec 07, 2022 | Post-IPO Equity - SAB Biotherapeutics | 1 | - | 7.9M |
| Oct 02, 2023 | Post-IPO Equity - SAB Biotherapeutics | 7 | - | 130.0M |
| Sep 07, 2016 | Grant - SAB Biotherapeutics | 1 | - | 1.4M |
Recent Activity
There is no recent news or activity for this profile.